About 1 result found for searched term "1222102-29-5" (0.144 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M27969 | Evogliptin | Dipeptidyl Peptidase |
| DA-1229 | ||
| Evogliptin (DA-1229) is an orally active DPP4 inhibitor with significant and sustained hypoglycaemic effects in mouse models. Evogliptin also inhibits the production of inflammatory and fibrotic signals in hepatocytes by inducing autophagy. Evogliptin can be used in studies of type 2 diabetes, osteoporosis, renal impairment and chronic liver inflammation. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
